GBIPharma
Home About_us Product Services Events contact_us
  WHO WE ARE
  GBI PRESSROOM
  GBI NEWS
  CAREERS
HOME > ABOUT US > WHO WE ARE  
who we are
 
Matthew Chervenak
Matthew Chervenak
Chief Executive Officer
 
Matthew founded GBI in Shanghai in 2002. His areas of focus include strategy development, deal sourcing, due diligence, drug discovery, outsourcing, and industry data. He previously worked at Sapient Corporation in New York City, NYU Medical Center, and the National Institutes of Health. Matthew is the Chairman of American Chamber of Commerce - Shanghai Healthcare Committee.
Contact: mcherv@generalbiologic.com
 
 
Matthew Chervenak
Jonathan Zifferblatt, MD, MBA, MPH
Managing Director
 
Jon joined GBI in early 2008. His areas of focus include due diligence, market assessments, physician practice and prescribing patterns, and healthcare systems and delivery. He has previous experience in management roles in the pharmaceutical and banking industries and is a US and PRC licensed physician. Jon is the Vice-chair of American Chamber of Commerce - Shanghai Healthcare Committee.
Contact: jziff@generalbiologic.com
 
 
Consultants and analysts

Our team of consultants and analysts is a mix of local and foreign professionals, many of whom possess PHD, MD and MBA degrees. Past working experiences include roles within the life science, pharmaceutical, medical, and financial industries. Our consultants and analysts, operating at the center of information integration within GBI, bring a wide range of perspectives to their client engagements.
 
 
Engineers

Our engineering team develops the infrastructure and platform to collect, integrate, and deliver information to our clients. With deep expertise in the tools and application of information technology, and a forward thinking web-based mindset, engineers play a central role at GBI.
 
 
 
 
Copyright © 2012 GB GROUP LIMITED. ALL RIGHTS RESERVED.